Resolve AI, the production-operations startup backed by Greylock and Lightspeed Venture Partners, today announced a sweeping ...

V2X (VVX) rated Hold as shares near $80–$82 intrinsic value; strong Q1, $13.8B backlog, higher EPS guide, key risks.

SHELTON, CT / ACCESS Newswire / May 15, 2026 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), reports that it ...

Become a channel sponsor, and you'll get access to exclusive bonuses. Learn more: <a ...

But GOP leaders are turning to the MAGA base to serve up two things this week: red meat with a side of revenge. Then come ...

Detailed price information for Quantum Computing Inc (QUBT-Q) from The Globe and Mail including charting and trades.

Despite the concerns surrounding the Iran War, Haig Bathgate, CEO of Callanish Capital, stated on CNBC on May 7 that he was ...

The Ebola outbreak in the Democratic Republic of Congo (DRC) is spreading rapidly, prompting the World Health Organization (WHO) on Friday to revise its risk assessment to "very high" at the national ...

For ASX healthcare stocks presentations at specialist medical conferences along with publications in peer-reviewed journals ...

Emergent BioSolutions (NYSE:EBS), a global biodefense company, today announced that the Saudi Food and Drug Authority (SFDA) has approved the registration of ACAM2000® [Smallpox and Mpox  (Vaccinia) ...

(OTCQB: OTLC) (profile) are responding to this challenge with next-generation delivery platforms engineered to circumvent biological barriers and ensure direct, targeted access to the central nervous ...

SERB Pharmaceuticals (“SERB”) and Hansa Biopharma AB (“Hansa”) (Nasdaq Stockholm: HNSA) today announced that they have entered into an agreement under which SERB will acquire the exclusive development ...